Total Funding
56
61
Total FundingGrant raised
Growth Score
-7 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
18941
Swing Therapeutics provides digital therapeutics for people with chronic conditions.
Mike Rosenbluth: CEOPast Role: Veracyte, Vice President of Pulmonology
Eric Hoppe: Head of Software EngineeringPast Role: RPX Corporation, VP, Systems Development
About the Company
Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain
control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.
